Mediaboss Marketing

Dublin, Aug. 11, 2020 (GLOBE NEWSWIRE) -- The "Smart Workplace Solutions and Integrated Workplace Management Systems by Technology, Connectivity, Applications, Device Type, Service Delivery Models, and Industry Verticals 2020 - 2025" report has been added to ResearchAndMarkets.com's offering.

This report provides an analysis of the smart workplace including market trends, growth drivers, market challenges, leading companies, solutions, applications, and services. The report analyzes market segments by categories, product and services, connectivity and communication technology, and regions, providing forecasts from 2020 to 2025.

The report also analyzes smart workplace solution providers with specific market recommendations. In addition, the report evaluates IWMS technology and applications with an assessment of business opportunities and market outlook. Report forecasts include the smart workplace market by technology, connectivity type, applications, device type, service delivery methods, and industry verticals.

The smart workplace is characterized as one that provides a safer, more comfortable, and productive work environment. Intelligent work is closely associated with intelligent buildings and smart facilities. In this context, it is related to various building automation solutions including smart lighting, smart security (such as access control via biometrics), intelligent HVAC systems, and more. Next-generation smart workplaces will include advanced technologies such as detection systems to determine the presence of employees for work space optimization.

While closely tied to smart buildings, it is important to note that the smart workplace is not tied to only a building space as remote work includes home workers, telecommuting, and work while traveling. Accordingly, a larger definition of the smart workplace includes technologies and solutions to enable more efficient and effective workflow and other business operation considerations. A broader definition of smart workplace takes into consideration those technologies and solutions that provide process improvement, workflow improvement, internal and external supply chain management optimization, visibility into product/service usage, opportunities for moving from products to services in an as a Service model, intelligent worker monitoring, data analytics, control of the entire Product Life Cycle (PLM), and more.

One of the most important solutions to optimize the smart workplace is to deploy an Integrated Workplace Management System (IWMS), which represents a combination of five separate modules (1) Property Management, (2) Facility and Space Management, (3) Maintenance Management, (4) Sustainability and Energy Management, and (5) Technology Management. With IWMS solutions, enterprise organizations are able to optimize asset utilization, energy consumption, technology deployment, building, and infrastructure efficiency, and overall workplace productivity to gain substantial savings in CAPEX and OPEX.

In terms of market developments since the last version of this report, the COVID-19 pandemic has served as a major catalyst for workplace evolution as employees and contractors have been forced to work remotely. This has tested corporate IT and facilities staff in terms of enterprise ability to cope with a highly distributed workforce while a minimal amount of essential staff occupy core business facilities.

Lessons learned from these few months have reinforced the long-held view of the author that the smart workplace ecosystem is much more than just smart buildings or other facilities such as warehouses. The smart workplace is indeed the sum of all assets, production, and processes. This includes core buildings and related infrastructure, inter-facility assets, and mobile/remote employees and their communications and collaboration tools.

Target Audience:

Select Report Findings:

Report Benefits:

Key Topics Covered:

1.0 Executive Summary

2.0 Smart Workplace Ecosystem2.1 Important Market Segments2.1.1 Workplace Product and Integrated Systems2.1.2 Workplace Transformation Services2.1.3 Integrated Workplace Management Systems2.2 Ecosystem Players2.2.1 Platform and Automation Solution Providers2.2.2 OEM Providers2.2.3 Networking and Infrastructure Solution Providers2.2.4 Security and Analytics Solution Providers2.2.5 Connectivity and Service Providers2.2.6 System Aggregators2.2.7 Enterprise End Users2.3 Facility Management and Life-Cycle Cost Analysis2.3.1 Facility Management Components2.3.2 Facility Management Cost Metrics2.3.3 Facility Management Cost Structure2.3.4 Facility Management Savings Structure2.4 Traditional Office vs. Software Driven Automation2.4.1 Enterprise SaaS Adoption2.4.2 SaaS Solution Costs2.4.3 Smart Workplace Job Market

3.0 Company Analysis

4.0 Smart Workplace Forecast Market Analysis and Forecasts4.1 Global Digital Twins 2020 - 20254.2 Smart Workplace by Building Type 2020 - 20254.3 Smart Workplace by Organization Type 2020 - 20254.4 Smart Workplace by Deployment 2020 - 20254.4.1 Smart Workplace Cloud Deployment by Business Model 2020 - 20254.5 Smart Workplace by Connectivity Protocol 2020 - 20254.6 Smart Workplace by Industry Vertical 2020 - 20254.7 Smart Workplace by Value Chain Partner 2020 - 20254.8 Smart Workplace by Region 2020 - 20254.9 Smart Workplace Segments 2020 - 20254.10 Smart Workplace Product and Integrated Systems 2020 - 20254.10.1 Smart Workplace Smart Lighting Systems 2020 - 20254.10.1.1 Smart Workplace Smart Lighting System by Lamp Type 2020 - 20254.10.1.1 Smart Workplace Smart Lighting Market by Component 2020 - 20254.10.2 Smart Workplace Robotics Automation by Product Type 2020 - 20254.10.2.1 Smart Workspace Applications Type 2020 - 20254.10.2.1 Smart Workplace Security and Access Control Type 2020 - 20254.10.3 Smart Workplace User Interface Devices Type 2020 - 20254.10.4 Smart Workplace Smart HVAC Product and Component Type 2020 - 20254.10.5 Smart Workplace Energy Management Services by Product Type 2020 - 20254.10.6 Smart Workplace Networking and Visual Market Product Type 2020 - 20254.10.7 Smart Workplace Entertainment System by Product 2020 - 20254.10.8 Smart Workplace Audio-Video Conferencing by Product Type 2020 - 20254.10.9 Smart Workplace Fire and Safety Control by Product Type 2020 - 20254.10.10 Smart Workplace Remote Communication by Product Type 2020 - 20254.10.11 Smart Workplace Healthcare by Product Type 2020 - 20254.11 Smart Workplace Transformation by Service Type 2020 - 20254.12 Integrated Smart Workplace Management System 2020 - 20254.13 Integrated Smart Workplace Management Application by Type 2020 - 20254.13.1 Integrated Property Management by Application Type 2020 - 20254.13.2 Integrated Maintenance Management by Application Type 2020 - 20254.13.3 Integrated Space and Move Management by Application Type 2020 - 20254.13.4 Integrated Technology Management by Application Type 2020 - 20254.14 Integrated Smart Workplace Management Solution by Type 2020 - 20254.15 Integrated Smart Workplace Management by Service Type 2020 - 20254.16 Integrated Smart Workplace Management Professional Service by Type 2020 - 2025

5.0 North America Smart Workplace Forecast 2020 to 2027

6.0 South America Smart Workplace Forecast 2020 to 2027

7.0 Europe Smart Workplace Forecast 2020 to 2027

8.0 APAC Smart Workplace Forecast 2020 to 2027

9.0 MEA Smart Workplace Forecast 2020 to 2027

10.0 Conclusions and Recommendations

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/62n0re

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Continued here:
Global Smart Workplace Solutions and Integrated Workplace Management Systems Market to 2025 - by Technology, Connectivity, Applications, Device Type,...

SINGAPORE - Extensions were granted to thenational service (NS) deferments of Olympics-bound swimmers Joseph Schooling and Quah Zheng Wen, the Ministry of Defence announced in a media release on Tuesday (Aug11).

Mindef said in its statement that both athletes' applications for extensions for the Tokyo Games - which were postponed by a year because of the coronavirus pandemic - were approved by the Armed Forces Council, and supported by the Ministry of Culture, Community and Youth.

Reigning 100m butterfly champion Schooling, 25, and Quah, 23, were both granted long-term deferment from NS to compete at the Tokyo Olympics, originally scheduled from July 24-Aug 9. In March, the quadrennial competition was postponed to July 23-Aug 8, 2021.

Should the Olympic Games be cancelled, both athletes will be scheduled for enlistment, added Mindef in its statement.

It said: "They have also committed to be fully focused in their preparations for the Olympic Games, in order to reach their peak form and will not undertake any additional activities such as commercial sponsorships.

"Mindef extends its best wishes to Mr Schooling and Mr Quah as they pursue national pride for Singapore in the Olympic Games in 2021."

Schooling said he was thankful to Mindef and MCCY "for their support and approval in the extension of my deferment from full-time National Service". He added: "This will allow me to continue unhindered on my Olympic journey. Training has always been and remains my first priority.

In May, Mindef said in response to ST queries that it was assessing Schoolingand Quah's applications for extensions to their deferments, adding it would engage them for details of their training plans and milestones in order to compete at the Olympics.

In a Facebook post on Tuesday, Minister for Culture, Community and Youth Edwin Tong said he was "very happy" that the extensions were approved.

"The Government is fully supporting their training and preparation in their bid for Olympic success," he said.

"I wish them the very best in their campaigns, and hope that they will continue to inspire national pride among Singaporeans!"

The rest is here:
Mindef grants extension to NS deferments for Olympics-bound Joseph Schooling and Quah Zheng Wen - The Straits Times

CamfilBacktoSchoolCovid-19

According to a report by the one way to make schools safer is to install high- efficiency air filters in the air handling units and by using stand-alone room air purifiers with HEPA filters as a supplement.

Riverdale, New Jersey, Aug. 09, 2020 (GLOBE NEWSWIRE) -- Although it would usually be the beginnings of the back-to-school season, parents and children across the country are left with uncertainty as to whether or not schools will be opening their doors. The Trump administration is making a push to reopen schools to full capacity in the fall. Some health experts agree as many schools overseas have opened, but others in the health industry do not agree with the reopening. The concern is while children have a lower risk of contracting COVID-19, masks and social distancing measures may not be enough to control the spread of the disease should asymptomatic students encounter adults once they are away from school.

If masks and social distancing arent enough to prevent the spread of COVID-19, what measures can we take instead?

Making Schools, Office Buildings, and Malls Safer with Air Filtration

According to a report by the Inside Edition, one way to make schools safer is to install high-efficiency air filters in the air handling units and by using stand-alone room air purifiers with HEPA filters as a supplement. The COVID-19 virus primarily spreads through infected respiratory droplets and possibly through droplet nuclei and aerosols, which are much smaller and lighter and can therefore, remain airborne for longer periods of time. Without proper air filtration, its possible these aerosols can get caught in the return of an HVAC system and recirculate into other parts of the building, thus spreading the infection further.

If a buildings ventilation system has the capacity, Camfil air filtration experts recommend an air filter labeled as a MERV-15A or MERV-16A. Unfortunately, some equipment is unable to accommodate the larger size of those filters. In those cases, a basic guideline would be to install the highest MERV-A that infrastructure can handle, saysGreg Herman, Camfils National Accounts Segment Manager.

About Camfil Clean Air Solutions

For more than half a century, Camfil worldwide has been helping people breathe cleaner air. As a leading manufacturer of premium clean air solutions, we provide commercial and industrial systems for air filtration and air pollution control that improve worker and equipment productivity, minimize energy use, and benefit human health and the environment. During the COVID-19 pandemic, Camfil has been applying their decades of experience in biosafety containment, healthcare, and other sectors of the air filtration industry to provide technological solutions for the public as well as in hospitals and healthcare facilities.

https://www.camfil.com/en-us

##

Media Contact:

Lynne Laake

Camfil USA Air Filters

T: 888.599.6620

E: Lynne.Laake@camfil.com

F: FriendCamfil USA on Facebook

T: FollowCamfil USA on Twitter

Y: WatchCamfil Videos on YouTube

L: Followour LinkedIn Page

News for Camfil via Camfil Newsroom onhttps://hvacairfiilters.submitmypressrelease.com

Follow Camfil blog for more storieshttps://cleanair.camfil.us

Here is the original post:
School Air Filtration Expert Weighs In on - Can We Safely Reopen Schools and Public Buildings This Fall? - GlobeNewswire

CAMBRIDGE, Mass. and GAINESVILLE, Fla., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, and the University of Florida today announced a strategic collaboration to enable cutting-edge research for novel genetic medicines. Through the agreement, Sarepta will fund multiple research programs at the University, and will have an exclusive option to further develop any new therapeutic compounds that result from the funded research programs.

We have developed a productive incubator approach to our pipeline development, partnering with the best and brightest in genetic medicine, including leading academic researchers like those at the University of Florida, to discover and translate into meaningful therapies genetic medicine for rare diseases, said Sarepta President and CEO Doug Ingram. Weare excited topartner with andsupportUF research that has the potentialto profoundlyimproveand extend the lives of patients with rare genetic-based diseases.

Through the collaboration, currently unique to UF, funding has been allocated for four innovative projects. These projects include exploratory research in novel gene therapy vectors, next-generation capsids and gene editing technologies as well as work in new therapeutic areas in degenerative genetic diseases. The goal is to foster early relationships with experts and accelerate the scientific advancements that lead to the development of transformational precision genetic medicines for patients in need.

Our researchers intend to find solutions for diseases that have no cure or limited therapeutic options. Their goal is to move these solutions from their labs to patients who need them to see their discoveries change lives. Because Sarepta has a focus and expertise in disease areas that coincide with the work of some of our scientists, its a match and collaboration that make sense and, we hope, will save lives, said Jim OConnell, assistant vice president of UF Innovate, the technology commercialization arm of the university. Sarepta has a bold vision for transforming genetic disease because the company, ultimately, serves patients. That end goal drives its willingness and ability to translate research into a medical reality. We want to be part of that.

University of Florida is a gene therapy powerhouse. UF researchers were the first to discover the life cycle of the adeno-associated virus (AAV), the smallest human virus. Using AAV as a benign delivery vehicle to carry therapeutics to a target, UF was first to reverse blindness in dogs with genetic disease, and UF researchers were integral in the first gene therapy approved by the FDA to treat an inherited genetic disease that can cause blindness. Today, UF is developing technologies in manufacturing, capsid design and therapies to address neuromuscular, cardiovascular, inflammatory, metabolic, pulmonary, skeletal, ophthalmic, and other disorders.

About SareptaAt Sarepta, we are leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with rare disease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development. The Companys programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing. For more information, please visitwww.sarepta.comor follow us onTwitter,LinkedIn,InstagramandFacebook.

Sarepta Forward-Looking Statements This press release contains "forward-looking statements." Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends," "potential," "possible" and similar expressions are intended to identify forward-looking statements. These forward-looking statements include statements regarding the ability of the collaboration between Sarepta and UF to engage in cutting-edge research for novel genetic medicines; Sareptas commitment to fund multiple research programs at UF; Sareptas option to further develop any new therapeutic compounds that result from the funded research programs; Sareptas incubator approach to discover and translate into meaningful therapies genetic medicine for rare diseases; the collaborations potential to profoundly improve and extend the lives of patients with rare genetic-based diseases; the collaborations ability to foster early relationships with experts to accelerate the scientific advancements that lead to the development of transformational precision genetic medicines; and Sareptas vision to transform genetic disease and translate research into a medical reality.

These forward-looking statements involve risks and uncertainties, many of which are beyond Sareptas control. Known risk factors include, among others: the expected benefits and opportunities related to the collaboration between Sarepta and UF may not be realized or may take longer to realize than expected due to challenges and uncertainties inherent in product research and development. In particular, the collaboration may not result in the discovery of any new therapeutic compounds or any viable treatments suitable for commercialization due to a variety of reasons, including any inability of the parties to perform their commitments and obligations under the agreement; Sarepta may not be able to execute on its business plans and goals, including meeting its expected or planned regulatory milestones and timelines, clinical development plans, and bringing its product candidates to market, due to a variety of reasons, many of which may be outside of Sareptas control, including possible limitations of company financial and other resources, manufacturing limitations that may not be anticipated or resolved for in a timely manner, regulatory, court or agency decisions, such as decisions by the United States Patent and Trademark Office with respect to patents that cover Sareptas product candidates and the COVID-19 pandemic; and those risks identified under the heading Risk Factors in Sareptas most recent Annual Report on Form 10-K for the year ended December 31, 2019, and most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) as well as other SEC filings made by Sarepta which you are encouraged to review.

Any of the foregoing risks could materially and adversely affect Sareptas business, results of operations and the trading price of Sareptas common stock. For a detailed description of risks and uncertainties Sarepta faces, you are encouraged to review the SEC filings made by Sarepta. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.

Contacts:

Sarepta Therapeutics Investors: Ian Estepan, 617-274-4052, iestepan@sarepta.comMedia: Tracy Sorrentino, 617-301-8566, tsorrentino@sarepta.com

UF Innovate: Sara Dagen, 352-294-0998, saradagen@ufl.edu

Continue reading here:
Sarepta Therapeutics and University of Florida Announce Collaboration to Accelerate the Discovery and Development of Therapies for Rare Genetic...

Google Chrome makes frequent updates, and some of the recent changes that have come have added some cool new features into the mix. You have probably already heard of Chromes tab freezing feature. It is a feature that allows you to essentially freeze a tab so that any autoplaying videos or audio tracks on the webpage dont unnecessarily use up your bandwidth in the background. This is an important feature and a big part of the reason why that is the case has to do with the fact that it would allow users to have more control over where their bandwidth is being funneled.

With all of that having been said and out of the way, it is important to note that there was another feature that came to Chrome recently and this was a tab collapsing feature. This feature allows you to collapse a group of tabs into a single, smaller tab that you can then access as and when needed. The main purpose of this was to make it so that you could potentially end up clearing your tab bar up which can often be a real problem for people that are attempting to do research, something that necessitates the opening of a large number of tabs at the end of the day.

Now you are going to have the option to collapse a group of tabs and also freeze them. This amalgamation of two important features will be quite useful once all has been said and is now out of the way. The reason behind this is that collapsed tabs can also use a lot of resources in the background, and freezing them can give you more options when it comes to allocating bandwidth. Collapsing a group of high bandwidth tabs and subsequently freezing them can be a very efficient way of streamlining bandwidth usage.

There are two updates coming to the global media control panel. The first is cast control, which basically means if you are casting media to an external device such as a Chromecast you would now be able to control the audio or video being casted through global media controls as well.

You will also get the option to select which audio device you want to cast the audio to, and the same goes for video devices. This gives users a lot more control over how their media is played and more importantly where it is played, coming together to enable Google to ensure that each and every user gets the exact experience they want.

With picture in picture mode as well as a variety of other features already having been added to the mix, the global media control panel is already becoming a popular feature for the average Chrome user. Adding in tab freezing and grouping gives further control to users and is a great step towards giving total media control to the user in question.

Sources: TechDows / 1 / 2.

Read next: Chrome 85 Will Now Generate Tagged PDFs When Users Will Print A Webpage

See more here:
Google Chrome Tests New Tab Freezing and Media Control Options - Digital Information World